Table 5.
Clinical efficacy of patients followed up after FMT T [cases n (%)].
| Groups | Followed up for 12 months | Followed up for 36 months | Followed up for 60 months | Follow-up lasted from 3 months to 7 years | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sum(n) | Clinical remission | Clinical improvement | Clinical invalid | Sum(n) | Clinical remission | Clinical improvement | Clinical invalid | Sum(n) | Clinical remission | Clinical improvement | Clinical invalid | ||
| CDI | 7 | 5 (71.4) | 0 | 2 (28.6) | 4 | 3 (75.0) | 1 (25.0) | 0 | 3 | 2 (66.6) | 0 | 1 (33.3) | One patients with constipation 6 months post-FMT |
| CID | 8 | 3 (37.5) | 2 (25.0) | 3 (37.5) | 6 | 2 (33.3) | 1 (16.6) | 3 (50.0) | 4 | 1 (25.0) | 1 (25.0) | 2 (50.0) | One patients with rhinitis 6 months post- FMT; one patients with constipation 1 year post- FMT; one patients with constipation 3 years post- FMT; |
| FC | 17 | 8 (47.1) | 2 (11.7) | 7 (41.1) | 10 | 4 (40.0) | 1 (10.0) | 5 (50.0) | 5 | 2 (40.0) | 0 | 3 (60.0) | NO |
| UC | 12 | 5 (41.6) | 1 (8.3) | 6 (50.0) | 9 | 3 (33.3) | 2 (22.2) | 4(44.4) | 3 | 1 (33.3) | 0 | 2 (66.6) | NO |
| AD | 6 | 2 (33.3) | 0 | 4 (66.6) | 5 | 1 (20.0) | 0 | 4 (80.0) | 4 | 1 (25.0) | 0 | 3 (75.0) | Five patients with rhinitis and two of them with underweight 3 years post-FMT |
| AC | 20 | 16 (80.0) | 0 | 4 (20.0) | 14 | 11 (78.6) | 1 (7.1) | 2 (14.2) | 6 | 5 (83.3) | 0 | 1 (16.6) | Eight patients with rhinitis and three of them with underweight 2 years post-FMT, three patients with constipation 1 years post- FMT |
CDI, C. difficile infection; AC, infantile allergic colitis; CID, chronic intractable diarrhea; UC, ulcerative colitis; AD, recurrent atopic dermatitis; FC, functional constipation; FMT, fecal microbiota transplantation.